potential indications for glp-1 receptor agonists keep expanding The scope of agonists: Six uses beyond diabetes Safety and Tolerability of Glucagon-Like
Description
Its generally safe for diabetics but its side effects and variable effectiveness in non-diabetics mean proceed with caution

Hauge-Evans, A

There have also been reports of people looking for weight loss help turning to multiple other drug solutions as a result of difficulty finding GLP-1 drugs

While this may limit the generalizability of the studys outcomes to a certain degree, the overall trend remained consistent across all racial and ethnic groups

SID Members

Current clinical guidelines reflect this evolving evidence
